Medication info
Telmisartan Tablets 40 mg (Telmisartan)

Telmisartan Tablets 40 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
Green Cross Corp.
Appearance
White or off-white oval tablets
Packaging
30 tablets (10 tablets/PTPX3)
Approval status
Active

MFDS item code 201003095 · Notified 2010.04.27 · Insurance code 644501760

Summary

Main use
Treatment of essential hypertension; prevention of cardiovascular diseases (including myocardial infarction and stroke)
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after the start of treatment. This drug has an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this drug be administered orally at a dose of 80 mg once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this drug to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Green Cross Corp.

Efficacy & effects

Treatment of essential hypertension; prevention of cardiovascular diseases (including myocardial infarction and stroke)

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attacks
  • clinical evidence of target organ damage in high-risk diabetes
View approved original text

This medication is primarily used for patients with essential hypertension. It also helps reduce the risk of cardiovascular disease in high-risk diabetic patients aged 55 and older with a history of coronary artery disease, peripheral artery disease, stroke, transient ischemic attacks, or evidence of target organ damage. This drug is effective in reducing the risk of death related to cardiovascular events such as myocardial infarction and stroke. It can be administered tolerably to patients for whom ACE inhibitors are difficult to use. Therefore, it is effectively used to reduce the risk of essential hypertension and cardiovascular diseases.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after the start of treatment. This drug has an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this drug be administered orally at a dose of 80 mg once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this drug to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This drug can cause serious harm to the fetus and newborn, especially during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. This medication should not be taken by individuals who are allergic to it or its ingredients, pregnant or breastfeeding women, people with severe liver impairment or bile duct obstruction, patients with hereditary angioedema, and those with certain kidney diseases. Elderly patients, those with high serum potassium levels, individuals with mild to moderate liver impairment, heart valve disease, cardiovascular disease, gastrointestinal disease, renal artery hypertension, and patients with severely impaired kidney function should take this medication with caution. This medication may cause various adverse reactions such as hyperkalemia, renal dysfunction, hypotension, allergic reactions, and liver function abnormalities, so it is important to monitor symptoms during use and consult a doctor immediately if adverse symptoms occur. In particular, if symptoms such as a sudden drop in blood pressure, dizziness, fainting, dyspnea, and swelling of the face, lips, or tongue occur, immediate medical treatment should be sought. Patients with renal impairment or those who have undergone kidney transplantation should have their potassium and creatinine levels monitored regularly. In cases of low blood volume or sodium depletion, there is a risk of hypotension, so conditions should be corrected before taking this medication. When taken with other antihypertensive agents, the blood pressure-lowering effect may be increased, and there may be a risk of renal function deterioration or hyperkalemia when taken with specific drugs, so current medications must be reported to the doctor. Women who are pregnant or planning to become pregnant should not take this medication, and breastfeeding women should avoid taking it or interrupt breastfeeding. Children under 18 years should not use this medication as its safety and efficacy are not established. Elderly patients should take the medication carefully to prevent excessively low blood pressure and be aware of dizziness or fainting during use. In cases of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur, necessitating immediate medical attention for appropriate treatment. This medication should be stored out of reach of children and kept sealed until just before use to protect its quality. Caution should be exercised while driving or operating dangerous machinery as there may be a risk of dizziness or fainting due to hypotensive effects.

Side effects

  • Upper respiratory tract infections
  • pharyngitis
  • sinusitis
  • urinary tract infections
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 104 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • vision disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • shortness of breath
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbances
  • abnormal liver function
  • liver disorder
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • low back pain
  • muscle cramp
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • increased liver enzymes
  • elevated serum creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • fatigue
  • appetite disturbance
  • cold sweats
  • tremor
  • decreased concentration
  • convulsions
  • altered consciousness
  • facial swelling
  • lip swelling
  • pharyngeal and laryngeal swelling
  • tongue swelling
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • loss of consciousness
  • jaundice
  • respiratory distress
  • blood pressure drop
  • laryngeal edema
  • fever
  • pneumonia
  • myalgia
  • elevated creatine kinase
  • increased serum myoglobin
  • increased urinary myoglobin
  • palpitations
  • fatigue
  • nausea
  • inadequate response
  • headache
  • dizziness
  • facial spasm
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • appetite suppression
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial swelling
  • rash
  • hair loss
  • conjunctivitis
  • tinnitus
  • petechiae
  • arrhythmia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from exposure to air or moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius. This will help maintain the effectiveness of the medication and ensure safe usage.

Appearance and packaging

Appearance

White or off-white oval tablets

Package unit

30 tablets (10 tablets/PTPX3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.